Literature DB >> 6556004

Serious infections due to group G streptoccocci. Report of 15 cases with in vitro-in vivo correlations.

K Lam, A S Bayer.   

Abstract

Serious infections due to group G streptococci have been infrequently reported. Fifteen such cases are described. Endovascular infection, particularly endocarditis, and septic arthritis were the most common clinical syndromes observed. Despite exquisite in vitro sensitivity of group G streptococci to penicillin G, the in vivo clinical response was disappointing in six of nine patients with either endocarditis or septic arthritis. The group G streptococcal isolates from the patients in this study were uniformly sensitive to the inhibitory and killing action of penicillin G, ampicillin, cefotaxime, cephalothin, cefoxitin, and vancomycin. In contrast, clindamycin, erythromycin, and chloramphenicol had relatively poor bactericidal activity against these strains, including several "tolerant" strains. Timed-kill studies with penicillin G revealed impaired killing of group G streptococci at in vitro conditions of high inocula and stationary growth phases. This may partially explain the poor clinical responses in cases of group G streptococcal endocarditis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6556004     DOI: 10.1016/0002-9343(83)90434-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  20 in total

1.  Group G streptococcal M protein exhibits structural features analogous to those of class I M protein of group A streptococci.

Authors:  C M Collins; A Kimura; A L Bisno
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

2.  M proteins of group G streptococci isolated from bacteremic human infections.

Authors:  A L Bisno; D E Craven; W R McCabe
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

3.  Postpartum pericarditis.

Authors:  Syed Kashan Abidi; Ronald Mastouri; M Chadi Alraies
Journal:  BMJ Case Rep       Date:  2014-10-01

4.  Susceptibility of group B and group G streptococci to newer antimicrobial agents.

Authors:  K V Rolston
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

5.  Binding of native alpha 2-macroglobulin to human group G streptococci.

Authors:  H P Müller; L K Rantamäki
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

6.  Septicemia and endocarditis caused by group G streptococci in a Norwegian hospital.

Authors:  A Bucher; P Gaustad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-04       Impact factor: 3.267

7.  Erysipelas and group G streptococci.

Authors:  M Hugo-Persson; K Norlin
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

8.  Clinical features and antimicrobial therapy of infections caused by group G streptococci.

Authors:  K V Rolston; P H Chandrasekar; J L LeFrock
Journal:  Infection       Date:  1985 Sep-Oct       Impact factor: 3.553

Review 9.  Recovery of uncommon bacteria from blood: association with neoplastic disease.

Authors:  J L Beebe; E W Koneman
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

10.  Group G streptococcal arthritis and bowel disease: a rare enteropathic arthropathy.

Authors:  S W Trenkner; E M Braunstein; M D Lynn; R W Ike
Journal:  Gastrointest Radiol       Date:  1987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.